Olaplex Holdings, Inc. announced its first acquisition since its inception over ten years ago, purchasing Purvala Bioscience, a Boston-based biotech company. Purvala was founded in 2020 by Drs. Bradley Olsen, Justin Paloni, and their colleagues, focusing on developing bioinspired technologies.
Purvala Bioscience specializes in creating high-performing molecules inspired by naturally occurring biological structures, with applications across health and beauty industries. Dr. Olsen also holds a position as a Professor of Chemical Engineering at MIT, bringing academic rigor to the acquired expertise.
This acquisition is a strategic move for Olaplex, aiming to leverage Purvala's expertise to create the next generation of disruptive, science-backed product innovations. The integration of Purvala's technologies is expected to complement Olaplex's existing patent-protected bond-building technology, Bis-aminopropyl diglycol dimaleate, and support its 'Bonds and Beyond' vision for foundational hair health.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.